SPRY 8-K 2026-06-25

ARS Pharmaceuticals, Inc. (SPRY) 8-K dated 2026-06-25 — accession 0001193125-26-282994. This URL is the filing, not the SPRY hub.

ARS Pharmaceuticals, Inc. (SPRY) is a biotechnology company listed on NASDAQ.

ARS Pharmaceuticals, Inc. filed a 8-K on 2026-06-25. Accession 0001193125-26-282994.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SPRY revenue for 2025-12-31 was $84.3M. Net income was -$171.3M. Revenue was down 5.5% from 2024-12-31 to 2025-12-31. SPRY currently screens at market cap $983.1M.

Not investment advice. The SPRY SEC hub lists recent forms. The stock page is the research view.